CompletedPHASE2, PHASE3NCT00444613

A Study in Patients With Amyotrophic Lateral Sclerosis (ALS)

Studying Amyotrophic lateral sclerosis

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Eisai Co., Ltd.
Principal Investigator
Kazunori Saeki
Neuroscience Clinical Development Section. JAC PCU. Eisai Co., Ltd.
Intervention
E0302 (mecobalamin)(drug)
Enrollment
373 enrolled
Eligibility
20 years · All sexes
Timeline
20072014

Study locations (30)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT00444613 on ClinicalTrials.gov

Other trials for Amyotrophic lateral sclerosis

Additional recruiting or active studies for the same condition.

See all trials for Amyotrophic lateral sclerosis

← Back to all trials